Biopharma company NOXXON raises €33m | AltAssets Private Equity News

Subscribe today

Advanced
Search

Biopharma company NOXXON raises €33m

27 May 2010

NOXXON Pharma, a Berlin-based biopharmaceuticals company developing oligonucleotide therapeutics for the treatment of cancer and diabetes, has raised a €33m Series D round led by new investor NGN Capital.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.